BIRMINGHAM, Ala.—Macular Health, a provider of nutritional supplements and vision care products, was recently acquired by a private equity group, who will change the parent company name to Lunovus and expand their product lines beyond eyecare in early 2016, according to Jeffery McAnnally, president and co-founder of Macular Health. McAnnally would not disclose specific financial data on the acquisition, but values the 12-year-old Macular Health company at $15 million.

Operations for Lunovus will remain in Birmingham, Ala. where McAnnally and retinal specialist John O. Mason, III, MD founded the company in 2003 to provide alternative treatments for patients suffering from dry eye syndrome, macular degeneration, blepharitis and other common eye diseases and conditions.

"Dr. Mason and I are extremely pleased with our new partners and their efforts to further expand our product lines throughout the United States and around the globe," said McAnnally. Both McAnnally and Dr. Mason, retina specialist at the UAB Callahan Eye Foundation Hospital, will remain actively involved with Lunovus and retain large equity ownership positions within the new company.

Lunovus will continue to provide a full line of Macular Health's nutritional supplements like AREDS, genetic specific vitamins and dry eye formulations, McAnnally said.